Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by monty15on Apr 05, 2018 12:58pm
226 Views
Post# 27836913

Insider buying is good !!!!!!

Insider buying is good !!!!!!Who is Martin Leclerc.......can't find him on PLI website ? BOD or management 
  • Apr 03, 2018 (filed on Apr 03, 2018)
    Insider Name:
    Leclerc, Martin
    Ownership Type:
    Indirect Ownership
    Securities:
    Common Shares
    Nature of Transaction:
    10 - Acquisition or disposition in the public market
    # or value acquired/disposed of:
    20,000
    Price:
    $0.74
Bullboard Posts